Antidiabétique, gliptine, inhibiteur de la dipeptidyl peptidase-4 (DPP-4) DCI : Sitagliptine

This page lists drugs marketed in Morocco belonging to the therapeutic class "Antidiabétique, gliptine, inhibiteur de la dipeptidyl peptidase-4 (DPP-4) DCI : Sitagliptine". For each entry, you'll find the brand name, composition (DCI), dosage, galenic form, manufacturer, public selling price (PPV in MAD) and reimbursement status (CNSS / CNOPS). Primary source: Direction du Médicament et de la Pharmacie (DMM), Ministry of Health.